Invivyd, Inc. announced that Laura Walker, Ph.D., the company's chief scientific officer and co-founder, decided to leave the company to pursue other opportunities. The management team has initiated a search process to identify her replacement. Until a permanent successor is named, Invivyd team member Lukas Dillinger, Ph.D., has been appointed as interim Head of Discovery and Pre-Clinical.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.395 USD | +1.05% | +11.40% | -39.21% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-39.21% | 283M | |
-1.18% | 103B | |
+7.94% | 101B | |
+4.40% | 23.07B | |
-12.21% | 22.23B | |
-4.36% | 18.05B | |
-39.98% | 17.18B | |
-10.64% | 16.94B | |
+6.72% | 14.07B | |
+38.30% | 12.35B |
- Stock Market
- Equities
- IVVD Stock
- News Invivyd, Inc.
- Invivyd, Inc. Announces Executive Changes